Search Results

Studies from Meyer Children's Hospital Reveal New Findings on Cystic Fibrosis (Microbiology of cystic fibrosis persons not chronically infected with P. aeruginosa: A quasi-experimental study on two different upper airways' sampling methods)

• Source: Health & Medicine Week. March 22, 2024, 6648

Record details

The Impact of Highly Effective Modulator Therapy on Cystic Fibrosis Microbiology and Inflammation.

• Authors : Caverly LJ; Department of Pediatrics, University of Michigan Medical School, L2221 UH South, 1500 East Medical Center Drive, Ann Arbor, MI 48109-5212, USA.; Riquelme SA

Subjects: Cystic Fibrosis*/Cystic Fibrosis*/Cystic Fibrosis*/drug therapy ; Quinolones*/Quinolones*/Quinolones*/therapeutic use; Humans

• Source: Clinics in chest medicine [Clin Chest Med] 2022 Dec; Vol. 43 (4), pp. 647-665.Publisher: Elsevier Health Sciences Division Country of Publication: United States NLM ID: 7907612 Publication Model: Print Cited Medium: Internet

Record details

Airway Infection in Cystic Fibrosis: Microbiology and Management.

• Authors : Waters VJ; Division of Infectious Diseases, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.; LiPuma JJ

Subjects: Cystic Fibrosis*/Cystic Fibrosis*/Cystic Fibrosis*/complications ; Cystic Fibrosis*/Cystic Fibrosis*/Cystic Fibrosis*/microbiology ; Cystic Fibrosis*/Cystic Fibrosis*/Cystic Fibrosis*/therapy

• Source: Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2022 Sep 07; Vol. 11 (Suppl 2), pp. S1-S2.Publisher: Oxford University Press Country of Publication: England NLM ID: 101586049 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Studies from University of Nottingham Add New Findings in the Area of Cystic Fibrosis (Cystic fibrosis microbiology: Advances in antimicrobial therapy).

• Source: Health & Medicine Week. 2015, pages. 1468

Record details

Cystic Fibrosis: Microbiology and Host Response.

• Authors : Zemanick ET; Children's Hospital Colorado, University of Colorado School of Medicine, 13123 East 16th Avenue, B-395, Aurora, CO 80045, USA.; Hoffman LR

Subjects: Cystic Fibrosis/Cystic Fibrosis/Cystic Fibrosis/*microbiology ; Inflammation/Inflammation/Inflammation/*physiopathology ; Lung Diseases/Lung Diseases/Lung Diseases/*microbiology

• Source: Pediatric clinics of North America [Pediatr Clin North Am] 2016 Aug; Vol. 63 (4), pp. 617-36.Publisher: W.B. Saunders Country of Publication: United States NLM ID: 0401126 Publication Model: Print Cited Medium: Internet ISSN: 1557-8240

Record details

Cystic fibrosis microbiology: Advances in antimicrobial therapy.

• Authors : Waters V; Division of Infectious Diseases, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Canada. Electronic address: .; Smyth A

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*administration & dosage ; Cystic Fibrosis/Cystic Fibrosis/Cystic Fibrosis/*microbiology ; Respiratory Tract Infections/Respiratory Tract Infections/Respiratory Tract Infections/*drug therapy

• Source: Journal of cystic fibrosis : official journal of the European Cystic Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101128966 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Researchers from University of Calgary provide details of new studies and findings in the area of cystic fibrosis microbiology.

• Source: Biotech Week. 2010, pages. 1692

Record details

Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission.

• Authors : Saiman L; Siegel J ...

Subjects: Cross Infection/Cross Infection/Cross Infection/*prevention & control ; Cystic Fibrosis/Cystic Fibrosis/Cystic Fibrosis/*complications ; Infection Control/Infection Control/Infection Control/*standards

• Source: Infection control and hospital epidemiology [Infect Control Hosp Epidemiol] 2003 May; Vol. 24 (5 Suppl), pp. S6-52.Publisher: Cambridge University Press Country of Publication: United States NLM ID: 8804099 Publication Model: Print Cited Medium: Print ISSN:

Record details

Insights into cystic fibrosis microbiology from the European tobramycin trial in cystic fibrosis.

• Authors : Govan JR; Department of Medical Microbiology, University of Edinburgh Medical School, Teviot Place, Edinburgh EH8 9AG, Scotland, UK.

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*administration & dosage ; Cystic Fibrosis/Cystic Fibrosis/Cystic Fibrosis/*complications ; Pseudomonas Infections/Pseudomonas Infections/Pseudomonas Infections/*drug therapy

• Source: Journal of cystic fibrosis : official journal of the European Cystic Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101128966 Publication Model: Print Cited Medium: Print ISSN: 1569-1993 (Print)

Record details

Multiresistant non-fermentative gram-negative bacteria in cystic fibrosis patients: the results of an Italian multicenter study. Italian Group for Cystic Fibrosis microbiology.

• Authors : Taccetti G; Cystic Fibrosis Center, Meyer Hospital, University of Florence, Italy. ; Campana S

Subjects: Cystic Fibrosis/Cystic Fibrosis/Cystic Fibrosis/*microbiology ; Gram-Negative Aerobic Bacteria/Gram-Negative Aerobic Bacteria/Gram-Negative Aerobic Bacteria/*drug effects; Adolescent

• Source: European journal of epidemiology [Eur J Epidemiol] 1999 Jan; Vol. 15 (1), pp. 85-8.Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 8508062 Publication Model: Print Cited Medium: Print ISSN:

Record details